220 related articles for article (PubMed ID: 19139380)
1. Impaired vasodilator activity in deoxycorticosterone acetate-salt hypertension is associated with increased protein O-GlcNAcylation.
Lima VV; Giachini FR; Choi H; Carneiro FS; Carneiro ZN; Fortes ZB; Carvalho MH; Webb RC; Tostes RC
Hypertension; 2009 Feb; 53(2):166-74. PubMed ID: 19139380
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAcylation contributes to augmented vascular reactivity induced by endothelin 1.
Lima VV; Giachini FR; Carneiro FS; Carneiro ZN; Saleh MA; Pollock DM; Fortes ZB; Carvalho MH; Ergul A; Webb RC; Tostes RC
Hypertension; 2010 Jan; 55(1):180-8. PubMed ID: 19948983
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy decreases O-GlcNAc-modified proteins in systemic arteries of normotensive and spontaneously hypertensive rats.
Troiano JA; Potje SR; Graton ME; Silva DS; da Costa RM; Tostes RC; Antoniali C
Life Sci; 2021 Feb; 266():118885. PubMed ID: 33316265
[TBL] [Abstract][Full Text] [Related]
4. Extracellular signal-regulated kinase 1/2 activation, via downregulation of mitogen-activated protein kinase phosphatase 1, mediates sex differences in desoxycorticosterone acetate-salt hypertension vascular reactivity.
Giachini FR; Sullivan JC; Lima VV; Carneiro FS; Fortes ZB; Pollock DM; Carvalho MH; Webb RC; Tostes RC
Hypertension; 2010 Jan; 55(1):172-9. PubMed ID: 19901158
[TBL] [Abstract][Full Text] [Related]
5. Tempol, an antioxidant, restores endothelium-derived hyperpolarizing factor-mediated vasodilation during hypertension.
Adeagbo AS; Joshua IG; Falkner C; Matheson PJ
Eur J Pharmacol; 2003 Nov; 481(1):91-100. PubMed ID: 14637180
[TBL] [Abstract][Full Text] [Related]
6. Differential contribution of endothelial function to vascular reactivity in conduit and resistance arteries from deoxycorticosterone-salt hypertensive rats.
White RM; Rivera CO; Davison CB
Hypertension; 1996 Jun; 27(6):1245-53. PubMed ID: 8641731
[TBL] [Abstract][Full Text] [Related]
7. Grape Extract from Chardonnay Seeds Restores Deoxycorticosterone Acetate-Salt-Induced Endothelial Dysfunction and Hypertension in Rats.
Sato A; Nishioka S; Kiuchi M; Imada Y; Makino K; Nakagawa K; Tanaka R; Matsumura Y; Ohkita M
Biol Pharm Bull; 2020; 43(1):59-67. PubMed ID: 31902933
[TBL] [Abstract][Full Text] [Related]
8. Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats.
Nunes VW; Fortes ZB; Nigro D; Carvalho MH; Zorn TM; Scivoletto R
Gen Pharmacol; 2000 Feb; 34(2):117-25. PubMed ID: 10974419
[TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction in DOCA-salt-hypertensive mice: role of neuronal nitric oxide synthase-derived hydrogen peroxide.
Silva GC; Silva JF; Diniz TF; Lemos VS; Cortes SF
Clin Sci (Lond); 2016 Jun; 130(11):895-906. PubMed ID: 26976926
[TBL] [Abstract][Full Text] [Related]
10. Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats.
Brown L; Ooi SY; Lau K; Sernia C
Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):263-9. PubMed ID: 10779123
[TBL] [Abstract][Full Text] [Related]
11. Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats.
Matsumoto T; Tostes RC; Webb RC
Pharmacol Res; 2012 Jan; 65(1):81-90. PubMed ID: 21933714
[TBL] [Abstract][Full Text] [Related]
12. Impaired β-adrenoceptor-induced relaxation in small mesenteric arteries from DOCA-salt hypertensive rats is due to reduced K(Ca) channel activity.
Matsumoto T; Szasz T; Tostes RC; Webb RC
Pharmacol Res; 2012 May; 65(5):537-45. PubMed ID: 22388053
[TBL] [Abstract][Full Text] [Related]
13. ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension.
Callera GE; Touyz RM; Teixeira SA; Muscara MN; Carvalho MH; Fortes ZB; Nigro D; Schiffrin EL; Tostes RC
Hypertension; 2003 Oct; 42(4):811-7. PubMed ID: 12913063
[TBL] [Abstract][Full Text] [Related]
14. Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction.
Hilgers RH; Xing D; Gong K; Chen YF; Chatham JC; Oparil S
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H513-22. PubMed ID: 22777418
[TBL] [Abstract][Full Text] [Related]
15. Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/ cSRC pathway.
Wenceslau CF; Rossoni LV
J Hypertens; 2014 Mar; 32(3):542-54. PubMed ID: 24309491
[TBL] [Abstract][Full Text] [Related]
16. Uric acid does not affect the acetylcholine-induced relaxation of aorta from normotensive and deoxycorticosterone acetate-salt hypertensive rats.
Szasz T; Watts SW
J Pharmacol Exp Ther; 2010 Jun; 333(3):758-63. PubMed ID: 20215410
[TBL] [Abstract][Full Text] [Related]
17. The influence of DOCA-salt hypertension and chronic administration of the FAAH inhibitor URB597 on K
Kloza M; Baranowska-Kuczko M; Malinowska B; Karpińska O; Harasim-Symbor E; Kasacka I; Kozłowska H
Vascul Pharmacol; 2017 Dec; 99():65-73. PubMed ID: 29038048
[TBL] [Abstract][Full Text] [Related]
18. Activation of hexosamine pathway impairs nitric oxide (NO)-dependent arteriolar dilations by increased protein O-GlcNAcylation.
Beleznai T; Bagi Z
Vascul Pharmacol; 2012; 56(3-4):115-21. PubMed ID: 22155161
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase inhibition reduces blood pressure elevation and vascular reactivity dysfunction caused by inhibition of nitric oxide synthase in rats.
da Cunha V; Rossoni LV; Oliveira PA; Poton S; Pretti SC; Vassallo DV; Stefanon I
Clin Exp Hypertens; 2000 Feb; 22(2):203-15. PubMed ID: 10744360
[TBL] [Abstract][Full Text] [Related]
20. Increased vascular O-GlcNAcylation augments reactivity to constrictor stimuli - VASOACTIVE PEPTIDE SYMPOSIUM.
Lima VV; Giachini FR; Carneiro FS; Carneiro ZN; Fortes ZB; Carvalho MH; Webb RC; Tostes RC
J Am Soc Hypertens; 2008; 2(6):410-7. PubMed ID: 19884969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
